SavedAdd your journal

Journals / Turkish Neurosurgery / 2019 / Cilt: 29 - Sayı: 5

Evaluation of the Retrogasserian Opioid Application in the Treatment of Idiopathic Trigeminal Neuralgia

Mustafa Kemal ILIK
Faik İLİK
Pages
631–634
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

All changes were statistically significant.CONCLUSION: Percutaneous retrogasserian opioid injection in type 1 trigeminal neuralgia is an effective and safe method of paincontrol.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To evaluate the clinical outcomes of the retrogasserian opioid application in patients with type 1 trigeminal neuralgia.MATERIAL and METHODS: A total of 37 patients (12 male, 25 female; average age 56.2 ± 5.4 years) who were administeredretrogasserian opioid due to type 1 trigeminal neuralgia between February 2012 and May 2015 were included in the study.
📊
Key Findings & Data:A visualanalogue scale was used to evaluate pain at the last preoperative and postoperative visits (median follow-up period: 13 months,mean follow-up period: 15.6 months).
💡
Conclusion & Impact:All changes were statistically significant.CONCLUSION: Percutaneous retrogasserian opioid injection in type 1 trigeminal neuralgia is an effective and safe method of paincontrol.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Özet

AIM: To evaluate the clinical outcomes of the retrogasserian opioid application in patients with type 1 trigeminal neuralgia.MATERIAL and METHODS: A total of 37 patients (12 male, 25 female; average age 56.2 ± 5.4 years) who were administeredretrogasserian opioid due to type 1 trigeminal neuralgia between February 2012 and May 2015 were included in the study. A visualanalogue scale was used to evaluate pain at the last preoperative and postoperative visits (median follow-up period: 13 months,mean follow-up period: 15.6 months). All parameters were analysed using Wilcoxon signed-rank and Mann-Whitney U tests, withp<0.05 considered statistically significant.RESULTS: Visual analogue scale scores of all 37 patients were significantly improved in the postoperative period. The averagevisual analogue scale scores were 7.9 ± 0.62 preoperatively and 2.9 ± 0.5 postoperatively. All changes were statistically significant.CONCLUSION: Percutaneous retrogasserian opioid injection in type 1 trigeminal neuralgia is an effective and safe method of paincontrol.

🔖

Cite This Article

ILIK, M. K., İLİK, F. (2019). Evaluation of the Retrogasserian Opioid Application in the Treatment of Idiopathic Trigeminal Neuralgia. Turkish Neurosurgery, Cilt: 29 - Sayı: 5, 631–634. https://ajindex.com/articles/405293

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Andres M: The pathophysiology of trigemina neuralgia. Lozano PG, Tasker RR (ed), Berlin: Springer, 2009 2. Chen JF, Tu PH, Lee ST: Long-term follow-up of patients treated with percutaneous balloon compression for trigeminal neuralgia in Taiwan. World Neurosurg 76:586-591, 2011 3. Cheng JS, Lim DA, Chang EF, Barbaro NM: A review of percutaneous treatments for trigeminal neuralgia. Neurosurgery 10:25-33, 2014 4. Civelek E, Cansever T, Imer M, Hepgul K, Barlas O: Trigeminal neuralgia and treatment options. Agri 17:19-26, 2005 5. Coven I, Dayisoylu EH: Evaluation of sphenopalatine ganglion blockade via intra oral route for the management of atypical trigeminal neuralgia. Springerplus 5: 906, 2016 6. Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, Nurmikko T, Zakrzewska JM: AAN-EFNS guidelines on trigeminal neuralgia management. European Journal of Neurology 15:1013-1028, 2008 7. Harries AM, Mitchell RD: Percutaneous glycerol rhizotomy for trigeminal neuralgia: Safety and eff icacy of repeat procedures. Br J Neurosurg 25:268-272, 2011 8. Hitchon PW, Holland M, Noeller J, Smith MC, Moritani T, Jerath N, He W: Options in treating trigeminal neuralgia: Experience with 195 patients. Clin Neurol Neurosurg 149:166-170, 2016 9. Huang Q, Liu X, Chen J, Bao C, Liu D, Fang Z, Liang X, Lu Z, Wan L: The effectiveness and safety of thermocoagulation radiofrequency treatment of the ophthalmic division (V1) and/ or maxillary (V2) and mandibular (V3) division in idiopathic trigeminal neuralgia: An observational study. Pain Physician 19:1041-1047, 2016 10. Kanpolat Y, Savas A, Bekar A, Berk C: Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1,600 patients. Neurosurgery 48:524-532, 2001 11. Kouzounias K, Schechtmann G, Lind G, Winter J, Linderoth B: Factors that influence outcome of percutaneous balloon compression in the treatment of trigeminal neuralgia. Neurosurgery 67:925-934, 2010 12. Montano N, Papacci F, Cioni B, Di Bonaventura R, Meglio M: The role of percutaneous balloon compression in the treatment of trigeminal neuralgia recurring after other surgical procedures. Acta Neurol Belg 114:59-64, 2014 13. Mullan S, Lichtor T: Percutaneous microcompression of the trigeminal ganglion for trigeminal neuralgia. J Neurosurg 59:1007-1012, 1983 14. Reddy VK, Parker SL, Patrawala SA, Lockney DT, Su PF, Mericle RA: Microvascular decompression for classic trigeminal neuralgia